- Tytuł:
- POS-045 Evaluating BCX9930, an Oral Factor D Inhibitor for Treatment of Complement-Mediated Kidney Disease: A Proof-of-Concept Study (RENEW)
- Autorzy:
- Źródło:
- In Kidney International Reports June 2022 7(6) Supplement:S457-S458
Czasopismo naukowe